Overexpression and hypomethylation of Flap endonuclease 1 gene in breast and other cancers

Purnima Singh, Ming Yang, Huifang Dai, Dianke Yu, Qin Huang, Wen Tan, Kemp H. Kernstine, Dongxin Lin, Binghui Shen

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Flap endonuclease 1 (FEN1) is a structure-specific nuclease best known for its critical roles in Okazaki fragment maturation, DNA repair, and apoptosis-induced DNA fragmentation. Functional deficiencies in FEN1, in the forms of somatic mutations and polymorphisms, have recently been shown to lead to autoimmunity, chronic inflammation, and predisposition to and progression of cancer. To explore how FEN1 contributes to cancer progression, we examined FEN1 expression using 241 matched pairs of cancer and corresponding normal tissues on a gene expression profiling array and validated differential expression by quantitative real-time PCR and immunohistochemistry. Furthermore, we defined the minimum promoter of human FEN1 and examined the methylation statuses of the 5′ region of the gene in paired breast cancer tissues. We show that FEN1 is significantly up-regulated in multiple cancers and the aberrant expression of FEN1 is associated with hypomethylation of the CpG island within the FEN1 promoter in tumor cells. The overexpression and promoter hypomethylation of FEN1 may serve as biomarkers for monitoring the progression of cancers.

Original languageEnglish (US)
Pages (from-to)1710-1717
Number of pages8
JournalMolecular Cancer Research
Volume6
Issue number11
DOIs
StatePublished - Nov 1 2008

Fingerprint

Flap Endonucleases
Breast Neoplasms
Genes
Neoplasms
Surgical Flaps
CpG Islands
Gene Expression Profiling
DNA Fragmentation
Autoimmunity
DNA Repair
Carcinogens
Methylation
Real-Time Polymerase Chain Reaction
Biomarkers
Immunohistochemistry

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Overexpression and hypomethylation of Flap endonuclease 1 gene in breast and other cancers. / Singh, Purnima; Yang, Ming; Dai, Huifang; Yu, Dianke; Huang, Qin; Tan, Wen; Kernstine, Kemp H.; Lin, Dongxin; Shen, Binghui.

In: Molecular Cancer Research, Vol. 6, No. 11, 01.11.2008, p. 1710-1717.

Research output: Contribution to journalArticle

Singh, Purnima ; Yang, Ming ; Dai, Huifang ; Yu, Dianke ; Huang, Qin ; Tan, Wen ; Kernstine, Kemp H. ; Lin, Dongxin ; Shen, Binghui. / Overexpression and hypomethylation of Flap endonuclease 1 gene in breast and other cancers. In: Molecular Cancer Research. 2008 ; Vol. 6, No. 11. pp. 1710-1717.
@article{7841ce06a74d454480d67a605926ce23,
title = "Overexpression and hypomethylation of Flap endonuclease 1 gene in breast and other cancers",
abstract = "Flap endonuclease 1 (FEN1) is a structure-specific nuclease best known for its critical roles in Okazaki fragment maturation, DNA repair, and apoptosis-induced DNA fragmentation. Functional deficiencies in FEN1, in the forms of somatic mutations and polymorphisms, have recently been shown to lead to autoimmunity, chronic inflammation, and predisposition to and progression of cancer. To explore how FEN1 contributes to cancer progression, we examined FEN1 expression using 241 matched pairs of cancer and corresponding normal tissues on a gene expression profiling array and validated differential expression by quantitative real-time PCR and immunohistochemistry. Furthermore, we defined the minimum promoter of human FEN1 and examined the methylation statuses of the 5′ region of the gene in paired breast cancer tissues. We show that FEN1 is significantly up-regulated in multiple cancers and the aberrant expression of FEN1 is associated with hypomethylation of the CpG island within the FEN1 promoter in tumor cells. The overexpression and promoter hypomethylation of FEN1 may serve as biomarkers for monitoring the progression of cancers.",
author = "Purnima Singh and Ming Yang and Huifang Dai and Dianke Yu and Qin Huang and Wen Tan and Kernstine, {Kemp H.} and Dongxin Lin and Binghui Shen",
year = "2008",
month = "11",
day = "1",
doi = "10.1158/1541-7786.MCR-08-0269",
language = "English (US)",
volume = "6",
pages = "1710--1717",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Overexpression and hypomethylation of Flap endonuclease 1 gene in breast and other cancers

AU - Singh, Purnima

AU - Yang, Ming

AU - Dai, Huifang

AU - Yu, Dianke

AU - Huang, Qin

AU - Tan, Wen

AU - Kernstine, Kemp H.

AU - Lin, Dongxin

AU - Shen, Binghui

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Flap endonuclease 1 (FEN1) is a structure-specific nuclease best known for its critical roles in Okazaki fragment maturation, DNA repair, and apoptosis-induced DNA fragmentation. Functional deficiencies in FEN1, in the forms of somatic mutations and polymorphisms, have recently been shown to lead to autoimmunity, chronic inflammation, and predisposition to and progression of cancer. To explore how FEN1 contributes to cancer progression, we examined FEN1 expression using 241 matched pairs of cancer and corresponding normal tissues on a gene expression profiling array and validated differential expression by quantitative real-time PCR and immunohistochemistry. Furthermore, we defined the minimum promoter of human FEN1 and examined the methylation statuses of the 5′ region of the gene in paired breast cancer tissues. We show that FEN1 is significantly up-regulated in multiple cancers and the aberrant expression of FEN1 is associated with hypomethylation of the CpG island within the FEN1 promoter in tumor cells. The overexpression and promoter hypomethylation of FEN1 may serve as biomarkers for monitoring the progression of cancers.

AB - Flap endonuclease 1 (FEN1) is a structure-specific nuclease best known for its critical roles in Okazaki fragment maturation, DNA repair, and apoptosis-induced DNA fragmentation. Functional deficiencies in FEN1, in the forms of somatic mutations and polymorphisms, have recently been shown to lead to autoimmunity, chronic inflammation, and predisposition to and progression of cancer. To explore how FEN1 contributes to cancer progression, we examined FEN1 expression using 241 matched pairs of cancer and corresponding normal tissues on a gene expression profiling array and validated differential expression by quantitative real-time PCR and immunohistochemistry. Furthermore, we defined the minimum promoter of human FEN1 and examined the methylation statuses of the 5′ region of the gene in paired breast cancer tissues. We show that FEN1 is significantly up-regulated in multiple cancers and the aberrant expression of FEN1 is associated with hypomethylation of the CpG island within the FEN1 promoter in tumor cells. The overexpression and promoter hypomethylation of FEN1 may serve as biomarkers for monitoring the progression of cancers.

UR - http://www.scopus.com/inward/record.url?scp=56449116122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449116122&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-08-0269

DO - 10.1158/1541-7786.MCR-08-0269

M3 - Article

VL - 6

SP - 1710

EP - 1717

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 11

ER -